InvestorsHub Logo
Followers 468
Posts 26929
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Friday, 05/29/2009 11:34:59 AM

Friday, May 29, 2009 11:34:59 AM

Post# of 208
10:56AM ViroPharma announces meeting of FDA Advisory Committee for pharmaceutical science and clinical pharmacology on bioequivalence recommendations for oral vancomycin hydrochloride products (VPHM) 6.99 +0.17 : Co announces that the FDA announced that it will convene a meeting of its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology to discuss bioequivalence recommendations for oral vancomycin hydrochloride capsule drug products. The meeting is scheduled for August 4, 2009. FDA will make background material available to the public no later than two days before the meeting. "ViroPharma views the convening of the advisory committee as a positive step towards open dialogue to discuss this very serious public health issue. ViroPharma will have an opportunity to address the Committee, and we look forward to what we hope will be a robust discussion of the many important issues raised by the Office of Generic Drugs' in vitro approach to bioequivalence for Vancocin."



surf's up......crikey